The nurse is instructing a client about the use of pegvisomant for the treatment of acromegaly. How will the nurse instruct to take this medication?
A) Injected subcutaneously once a day
B) Injected intramuscularly once a month
C) Administer via an implanted port once a month
D) Injected intramuscularly one every 6 months
A
Feedback:
Pegvisomant, a GH receptor antagonist, is the newest and most effective drug for treating acromegaly. Injected subcutaneously once a day, it normalizes the IGF-I level in 93% to 97% of cases by blocking the GH stimulation of IGF-1 produced by the liver.
You might also like to view...
The nurse educates a patient about the primary risk factors for irritable bowel syndrome. Which behavior by the patient would be evidence of learning? The patient:
a. Reduces her intake of gluten-containing products b. Does not consume foods that contain lactose c. Consumes only four cups of caffeinated coffee per day d. Takes measures to reduce her stress level
A patient with end-stage organ failure is being evaluated for an organ transplant. What factor is most likely to be a contraindication for transplant?
A) Age 30 to 55 years B) Absence of acute or chronic infection C) Cannot afford the cost of medications after transplant D) Is receiving maximum doses of organ support medications
For the nurse providing care to an immobilized patient, the most appropriate and most effective nursing intervention would be:
A) Getting the patient out of bed and into a chair for 30 minutes, twice daily. B) Avoiding repositioning the patient if he's comfortable. C) Repositioning the patient on alternate sides at least every 2 hours. D) Positioning the patient with the pressure on the bony prominence.
A client received maintenance doses of trifluoperazine (Stelazine) 30 mg po daily for 1.5 years. The
clinic nurse notes the client is grimacing and seems to be constantly smacking her lips. Her neck and shoulders twist in a slow, snakelike motion. The nurse should suspect the presence of a. agranulocytosis. b. tardive dyskinesia. c. Tourette's syndrome. d. anticholinergic effects.